Establishment Labs Holdings (ESTA) EBIT Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 7.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.25% |
| Dec 31, 2025 | 33.16% |
| Sep 30, 2025 | 27.40% |
| Jun 30, 2025 | -10.68% |
| Mar 31, 2025 | -44.86% |
| Dec 31, 2024 | -25.85% |
| Sep 30, 2024 | -13.26% |
| Jun 30, 2024 | -26.34% |
| Mar 31, 2024 | -61.53% |
| Dec 31, 2023 | -40.25% |
| Sep 30, 2023 | -100.99% |
| Jun 30, 2023 | -12.61% |
| Mar 31, 2023 | -1.93% |
| Dec 31, 2022 | -44.02% |
| Sep 30, 2022 | -6.26% |
| Jun 30, 2022 | -3.51% |
| Mar 31, 2022 | 12.73% |
| Dec 31, 2021 | -2.80% |
| Sep 30, 2021 | -14.37% |
| Jun 30, 2021 | 9.81% |
| Mar 31, 2021 | 10.05% |
| Dec 31, 2020 | -20.45% |
| Sep 30, 2020 | 24.29% |
| Jun 30, 2020 | -20.55% |